Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...
A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into ...
Morning Overview on MSN
Metformin may mimic exercise-linked metabolite in prostate cancer patients
Prostate cancer patients treated with the widely prescribed diabetes drug metformin showed elevated blood levels of N-lactoyl ...
Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...
Abstract Highlights Rinzimetostat is a potent and highly selective next-generation allosteric PRC2 inhibitor targeting the EED subunit that has demonstrated potential best-in-class efficacy and safety ...
Ideaya Biosciences begins patient dosing in phase 1 trial of IDE574, a potential first-in class dual inhibitor of KAT6/7 to target multiple solid tumour indications, including bre ...
The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative designed to advance equitable prostate cancer detection, diagnosis, and care in ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results